Literature DB >> 17185410

Varicella-zoster vaccine virus: evolution in action.

Jeffrey I Cohen1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17185410      PMCID： PMC1765479          DOI： 10.1073/pnas.0610016103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination.

Authors:  Winsome Barrett Muir; Richard Nichols; Judith Breuer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.

Authors:  Mark L Quinlivan; Anne A Gershon; Sharon P Steinberg; Judith Breuer
Journal:  J Infect Dis       Date:  2004-07-15       Impact factor: 5.226

4.  Herpes zoster following varicella vaccine in a child with acute lymphocytic leukemia.

Authors:  D L Williams; A A Gershon; L D Gelb; M K Spraker; S Steinberg; A H Ragab
Journal:  J Pediatr       Date:  1985-02       Impact factor: 4.406

5.  Live vaccine used to prevent the spread of varicella in children in hospital.

Authors:  M Takahashi; T Otsuka; Y Okuno; Y Asano; T Yazaki
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

6.  Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient.

Authors:  S E Straus; W Reinhold; H A Smith; W T Ruyechan; D K Henderson; R M Blaese; J Hay
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

7.  Postlicensure safety surveillance for varicella vaccine.

Authors:  R P Wise; M E Salive; M M Braun; G T Mootrey; J F Seward; L G Rider; P R Krause
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

8.  Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype.

Authors:  Charles Grose; Shaun Tyler; Geoff Peters; Joanne Hiebert; Gwen M Stephens; William T Ruyechan; Wallen Jackson; Johnathan Storlie; Graham A Tipples
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts.

Authors:  Kimiyasu Shiraki; Yoshihiro Yoshida; Yoshizo Asano; Koichi Yamanishi; Michiaki Takahashi
Journal:  J Infect Dis       Date:  2003-12-08       Impact factor: 5.226

10.  Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients.

Authors:  Y Hayakawa; S Torigoe; K Shiraki; K Yamanishi; M Takahashi
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226
View more
  2 in total

1.  Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.

Authors:  Daniel P Depledge; Samit Kundu; Nancy J Jensen; Eleanor R Gray; Meleri Jones; Sharon Steinberg; Anne Gershon; Paul R Kinchington; D Scott Schmid; Francois Balloux; Richard A Nichols; Judith Breuer
Journal:  Mol Biol Evol       Date:  2013-10-25       Impact factor: 16.240

2.  Effects of Shield1 on the viral replication of varicella‑zoster virus containing FKBP‑tagged ORF4 and 48.

Authors:  Shuying Li; Zhanjun Liu; Ji Li; Aihua Liu; Lihua Zhu; Kui Yu; Ke Zhang
Journal:  Mol Med Rep       Date:  2017-11-06       Impact factor: 2.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.